来自MSN3 个月
Research uncovers new mechanism in protein aggregation linked to Parkinson's disease
They administered 5-aminolevulinic acid (5-ALA), a compound that blocks G4 formation, to model mice exhibiting Parkinson's-like symptoms. Impressively, 5-ALA treatment not only prevented α ...
Lumeda Reports Progress In Clinical Evaluation Of Its Intraoperative Photodynamic Therapy
Lumeda Inc. ("Lumeda"), a biophotonics systems company formed to advance photodynamic therapy (PDT) for treating cancer, today announced the completion of a phase 1 clinical by Roswell Park ...
来自MSN3 个月
RNA structures present a promising target for early intervention in Parkinson's disease
They administered 5-aminolevulinic acid (5-ALA), a compound that blocks G4 formation, to model mice exhibiting Parkinson's-like symptoms. Impressively, 5-ALA treatment not only prevented α ...